The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers. (Q46832072)
Jump to navigation
Jump to search
scientific article published in October 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers. |
scientific article published in October 2005 |
Statements
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers (English)
Fulfaro F
Leto G
Badalamenti G
Arcara C
Cicero G
Valerio MR
Di Fede G
Russo A
Vitale A
Rini GB
Intrivici C
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference